About
Ofir Moreno, PhD, is SVP Drug Discovery at Rubedo Life Sciences, a longevity-focused biotech developing therapies targeting pathological senescent cells. Rubedo and Business Wire describe him as a veteran biotech executive with more than 25 years of pharmaceutical R&D experience across early discovery through clinical development. Before Rubedo, he was Senior Vice President of Pharmaceutical Sciences at MEI Pharma and previously held drug discovery roles at Merck, Amgen, Corvas International, and Dendreon.
Areas of interest
longevitybiotechdrug discoveryaging biologysenotherapeuticsmedicinal chemistryoncologyCNScardiovascular therapeuticsclinical development